| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.23B | +31.6% |
| Cost of Revenue | $312.5M | +41.2% |
| Gross Profit | $921.5M | +28.7% |
| R&D Expense | $291.2M | +22.1% |
| SG&A Expense | $191.8M | +21.7% |
| Operating Income | -$67.8M | +19.4% |
| Pre-tax Income | -$30.5M | +30.1% |
| Income Tax | $1.3M | -49.2% |
| Net Income | -$31.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.06B | +20.8% |
| Accounts Receivable | $60.7M | +40.9% |
| Current Assets | $1.21B | +23.1% |
| Total Assets | $1.58B | +24.1% |
| Current Liabilities | $282.2M | +41.2% |
| Total Liabilities | $384.0M | +60.5% |
| Stockholders' Equity | $1.20B | +15.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $218.0M | +31.4% |
| Capital Expenditures | $9.5M | +60.2% |
| Investing Cash Flow | -$30.5M | -77.0% |
| Financing Cash Flow | -$4.5M | +22.7% |
| Free Cash Flow | $208.5M | +30.3% |
| +31.2% |
| EPS (Basic) | -$0.11 | +35.3% |
| EPS (Diluted) | -$0.11 | +35.3% |